NCT06605807 Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions
| NCT ID | NCT06605807 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Prescribing Decisions |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-11-13 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-11-13 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot clinical trial is to learn if providing a clinical decision framework for managing older adults chronic conditions during hospitalization to inpatient clinicians improves clinicians' ability to individualize chronic condition prescribing decisions for hospitalized older adults (65 and older). The main questions it aims to answer are: * Will the clinical decision framework lead to clinicians having greater confidence to individualize discharge prescribing? * Will clinicians using the framework discharge make fewer changes to hospitalized older adults with home diabetes and hypertension medications than they did prior to receiving the framework? * Will older adult patients of participating clinicians will report fewer gaps in understanding of medication changes after the clinician is exposed to the framework? Researchers will compare participating clinician survey responses and prescribing records from before and after an educational session presenting the clinical decision framework. Participants will be asked to * Attend a one-time educational session on the clinical decision framework * Complete 2 electronic surveys, one before and one following the educational session. * Agree for researchers to contact their patients, in order for patients to complete a one-time phone survey about changes made to home medications during hospitalization and quality of communication from the hospital team.
Eligibility Criteria
Clinician Participants: Inclusion Criteria: 1. Attending clinicians who practice on the general medicine or hospital medicine service at UPMC Presbyterian, UPMC Montefiore, UPMC Shadyside, UPMC Mercy, or UPMC Magee-Women's Hospital campuses. 2. Practicing on the general medicine or hospital medicine service. This population may include physicians with training in general internal medicine, hospital medicine, family practice, internal medicine subspecialities, as well as advance practice clinicians. Exclusion Criteria: 1. Anticipating leaving current clinical position within next 3 months 2. Less than 4 weeks of inpatient attending service scheduled within 3 months of recruitment Patient Participants: Inclusion Criteria: 1. Adult aged 65 years or older who are hospitalized under the care of a participating clinician and discharged home. 2. Eligible patients must recieve at least one cardiometabolic medication change at hospital discharge (can include new medication starts, stops, or dose changes). Cardiometabolic medications include any class of antihypertensive, lipid lowering, anti-platelet, or glucose lowering medications regardless of indication for use. Exclusion Criteria: 1. Incapacity for informed consent / unable to answer survey questions due to cognitive impairment 2. Enrolled in hospice care
Contact & Investigator
Timothy S Anderson, MD, MAS
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06605807 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Prescribing Decisions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06605807 currently recruiting?
Yes, NCT06605807 is actively recruiting participants. Contact the research team at prescribingwiselylab@pitt.edu for enrollment information.
Where is the NCT06605807 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06605807 clinical trial?
NCT06605807 is sponsored by University of Pittsburgh. The principal investigator is Timothy S Anderson, MD, MAS at University of Pittsburgh. The trial plans to enroll 150 participants.